CUE
Cue Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.28
-0.02 ▼ -6.74%
🌙 3월 13일 7:33 PM ET (한국 3/14 08:33)
$0.27
-0.01 ▼ -4.27%
| Index | - | P/E | - | EPS (ttm) | -0.46 | Insider Own | 0.66% | Shs Outstand | 0.09B | Perf Week | -5.37% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | -17.5% | Insider Trans | 116.41% | Shs Float | 0.09B | Perf Month | -11.81% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.09 | Inst Own | 23.88% | Short Float | 1.97% | Perf Quarter | -40.56% |
| Income | -0.04B | P/S | 3.65 | EPS this Y | 44.44% | Inst Trans | 5.11% | Short Ratio | 1.34 | Perf Half Y | -62.95% |
| Sales | 0.01B | P/B | 1.67 | EPS next 5Y | 12.04% | ROA | -98.58% | Short Interest | 1.78M | Perf YTD | -7.11% |
| Book/sh | 0.17 | P/C | 1.39 | EPS past 3/5Y | 20.02% 15.39% | ROE | -195.19% | 52W High | -74.67% ($1.12) | Perf Year | -70.87% |
| Cash/sh | 0.2 | P/FCF | - | Sales past 3/5Y | -14.66% 21.84% | ROIC | -236.55% | 52W Low | 23.24% ($0.23) | Perf 3Y | -89.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 49.72% | Gross Margin | - | Volatility(W/M) | 12.59% 9.01% | Perf 5Y | -98.2% |
| Dividend TTM | - | EV/Sales | 1.88 | Sales Y/Y TTM | -25.51% | Oper. Margin | -536.72% | ATR (14) | 0.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.66 | EPS Q/Q | 56.33% | Profit Margin | -530.75% | RSI (14) | 42.4 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.66 | Sales Q/Q | -35.58% | SMA20 | -3.49% ($0.29) | Beta | 1.49 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.47 | Earnings | 11000000 | SMA50 | -12.25% ($0.32) | Rel Volume | 0.86 | Prev Close | $0.3 |
| Employees | 41 | LT Debt/Eq | 0.2 | EPS/Sales Surpr. | 24.97% -6.14% | SMA200 | -52.82% ($0.59) | Avg Volume(3M) | 1.33M | Price | $0.28 |
| IPO | 2018/1/2 | Option/Short | Yes/Yes | Trades | 1117 | Volume | 1,144,992 | Change | -6.74% |
뉴스 로딩 중...